Evidence map›Paper›PMID 40576281›Full record

ArticleThe Journal of dermatology2025

Perceived Stigma and Mental Health Disorders Among Adults With Alopecia Areata Living in Japan.

Norimitsu Saito, Kazumasa Kamei, Genevieve Gautier, Samantha K Kurosky, Kent A Hanson, Griffith Bell, Lulu Lee, Nikoletta Sternbach, Akira Yuasa

Abstract read
In one paragraph

Article in The Journal of dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Norimitsu SaitoNagomi Dermatology Clinic, Kanagawa, Japan.
Kazumasa KameiPfizer Japan Inc., Tokyo, Japan.ORCID https://orcid.org/0000-0001-7220-5142
Genevieve GautierPfizer Inc., Kirkland, Quebec, Canada.
Samantha K KuroskyPfizer Inc., New York, New York, USA.
Kent A HansonPfizer Inc., New York, New York, USA.
Griffith BellPfizer Inc., New York, New York, USA.
Lulu LeeOracle Life Sciences, Austin, Texas, USA.
Nikoletta SternbachOracle Life Sciences, Austin, Texas, USA.
Akira YuasaPfizer Japan Inc., Tokyo, Japan.ORCID https://orcid.org/0000-0002-3699-7231

Funding

Pfizer
6 · The paper itself

Abstract

Alopecia areata (AA) is a common disorder that causes hair loss and can significantly impact quality of life, which may be partially due to AA-related stigma. Examining the impact of AA on psychosocial health is important for understanding the burden experienced by patients with AA. The primary objective of this study was to examine mental health and sleep conditions, hair growth satisfaction, and AA-related stigma perceptions among individuals diagnosed with AA in Japan. The study used patients' self-reported data collected from the National Health and Wellness Survey conducted in Japan in 2023. Collected data included demographic characteristics and comorbidities; among those with a self-reported clinical diagnosis of AA, additional information on clinical characteristics, treatments, and perceived AA-related stigma was captured. Results were analyzed and stratified by self-assessed disease severity. Among the full sample (30 013 adults living in Japan), 471 respondents reported a clinical diagnosis of AA, including 347 mild cases, 100 moderate cases, and 24 severe cases. A diagnosed mental health disorder in the past year was reported by 57 respondents (12.1%), and 67 (14.2%) reported a diagnosed sleep condition in the past year. Less than half of respondents (47.4%) were satisfied with their current hair growth, and satisfaction decreased with increasing disease severity. Overall, 70.3% of respondents reported feelings of embarrassment, 55.0% felt that others judged them negatively, and 50.3% felt that others treated them negatively due to AA. A higher proportion of respondents with a severe case (54.2%) reported feeling embarrassed to have AA "very much so" compared with respondents who had mild (15.3%) or moderate (26.0%) cases. Perceived AA-associated stigma increased with disease severity. Overall, this study demonstrated the prevalence of AA-related disease stigma and mental health conditions among individuals with AA living in Japan, underscoring the importance of mental health support for patients with AA.

Indexed as

Alopecia AreataMental DisordersSocial StigmaAdultAgedFemaleHealth SurveysHumansJapanMaleMental HealthMiddle AgedPersonal SatisfactionQuality of LifeSelf ReportSeverity of Illness Indexalopecia areatacross‐sectional studiesJapanmental healthshame

Identifiers

PMID40576281
PMCPMC12315609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.